뉴스/Reuters/Dualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track DesignationDualitybio's Next-Generation Her3 Adc Db-1310 Granted FDA Fast Track DesignationRefinitiv1분 미만 읽기9606Duality Biotherapeutics Inc 9606:DUALITYBIO'S NEXT-GENERATION HER3 ADC DB-1310 GRANTED FDA FAST TRACK DESIGNATIONReuters미국 주식아시아중국 주식© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html더 보기이 뉴스를 읽으려면 로그인하거나 평생 무료 계정을 만드십시오렛츠고
